Lido Advisors Reduces $3M in Cardinal Health, Inc. ($CAH)

Lido Advisors has significantly reduced its position in Cardinal Health, Inc. (NYSE:CAH), according to a recent filing. The firm cut its holdings by 14,370 shares, a decrease of nearly 25%, leaving it with 43,149 shares valued at approximately $9.54 million as of the end of the reporting period.

What Changed in Lido Advisors' Cardinal Health Position

Lido Advisors' latest 13F filing reveals a substantial reduction in its stake in Cardinal Health. The firm slashed its holdings by 14,370 shares, moving from 57,519 shares to 43,149 shares. This represents a 24.98% decrease, with the remaining shares valued at about $9.54 million.

Other Institutional Activity in Cardinal Health

Institutional activity around Cardinal Health has shown varied strategies. BlackRock, Inc. slightly reduced its position by 146,765 shares, ending with 28,494,855 shares worth about $6.02 billion. In contrast, Vanguard Capital Management LLC and Vanguard Portfolio Management LLC both significantly increased their positions, adding 15,288,709 and 13,732,309 shares respectively, with holdings valued at $3.23 billion and $2.90 billion. State Street Corp cut its stake by 434,712 shares, while Geode Capital Management, LLC added 51,519 shares, bringing its total to 6,580,532 shares valued at $1.39 billion.

Cardinal Health Stock Snapshot

Shares of Cardinal Health (NYSE:CAH) are trading around $221.16. The company boasts a market cap of approximately $52.43 billion and a P/E ratio of 34.18. Its forward P/E stands at 18.66, indicating expectations of future growth. Cardinal Health's stock has ranged from a 52-week low of $137.75 to a high of $233.60, with moving averages of $202.54 (50-day) and $195.37 (200-day). The company has a beta of 0.526, suggesting lower volatility compared to the market.

Recent Earnings

In its latest earnings report, Cardinal Health posted revenue of $250.74 billion, reflecting a growth rate of 11%. The company's earnings per share (EPS) stood at $6.55, with a net margin of 0.62%. Its return on equity (ROE) was not disclosed. The next earnings release is scheduled for April 30, 2026.

Dividend

Cardinal Health offers an annual dividend rate of $2.05, yielding 0.93%. The dividend payout ratio is 31.19%, indicating a sustainable payout relative to earnings.

Insider Buying and Selling at Cardinal Health, Inc.

Recent insider activity at Cardinal Health includes Patricia Hemingway Hall purchasing 381 shares at an average price of $207.83 on April 15, 2026. On the selling side, Chief Information Officer Michelle Greene sold 2,746 shares at $228.47 on February 27, 2026, and Chief Financial Officer Aaron Alt sold a total of 6,570 shares in multiple transactions in February 2026, with prices ranging from $220.79 to $225.50.

Analysts Set New Price Targets

Analyst sentiment remains positive for Cardinal Health. On May 4, 2026, JP Morgan maintained a 'hold' rating with a $215 price target. Citigroup, TD Cowen, and Wells Fargo all maintained 'buy' ratings with price targets of $245, $255, and $245 respectively on May 1, 2026. The consensus among analysts is a 'strong buy', with an average target price of $245.27 based on 15 opinions.

About Cardinal Health

Cardinal Health, Inc. provides healthcare services and products in the U.S. and internationally. It operates through Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution segments. The company offers solutions for hospitals, healthcare systems, pharmacies, and more, distributing a wide range of pharmaceutical and medical products. Headquartered in Dublin, Ohio, Cardinal Health is led by CEO Jason M. Hollar and employs over 53,000 people.

Bottom Line

Lido Advisors' decision to cut its stake in Cardinal Health by nearly 25% is a notable move in the healthcare sector. Investors often track such changes in institutional holdings for insights into market sentiment. It's important to remember that 13F filings are backward-looking and may not reflect current positions.